Walder Wyss advised dsm-firmenich on the sale of Pentapharm and its Brazilian sister company Pentapharm do Brasil Comércio e Exportação to Orlando Capital V. Founded in 1948 and headquartered in Aesch, Pentapharm is a
Tags :Walder Wyss
Walder Wyss advised the Dec Group – a specialist in high-containment processing technologies for the pharmaceutical, chemical, and specialty industries – and its existing shareholders, throughout completion of a financial partnership with ICG, an alternative asset manager
Pestalozzi advised the shareholders of Swiss consulting firm abaQon in connection with company’s integration into the Eraneos Group – the latter being represented by Walder Wyss. The parties Headquartered in Zug, abaQon specialises in strategic
Walder Wyss advised Evulpo, a Swiss EdTech start-up, throughout completion of a CHF 8.8 million Series A financing round. The investors The round saw participation from new and existing investors, including Serpentine Ventures, as well as
Frutiger, a Swiss provider of construction and real estate services with around 2,500 employee completed the acquisition of a 30% participation in Blumer Lehmann, a Swiss timber construction and timber industry company with more than 600 employees. In
Walder Wyss advised askEarth, a Zurich-based deep-tech startup specialised in geospatial AI, in connection with the closing of its seed financing round. A spin-off from UZH, ETH and EPFL, the Swiss company raised an amount
Walder Wyss advised Cembra Money Bank and Zürcher Kantonalbank (ZKB) in connection with the establishment of a CHF 1 bn programme leading to the issuance of auto covered bonds by Cembra Money Bank itself, with
Walder Wyss advised Polaroid as the Swiss Federal Institute of Intellectual Property (IPI), after initially refusing the application, approved the registration of a colour mark for the brand. The trademark in question consists of
Wefox has secured funding of EUR 151 m, consisting of a EUR 76 m capital raise primarily from Chrysalis and other existing investors and a refinancing of an existing credit facility with EUR 75 m from Searchlight Capital
Walder Wyss advised biotech company Alvotech throughout its acquisition of the Ivers-Lee Group (Ivers-Lee). The parties Luxembourg-based Alvotech is a globally active biotech company specialising in the development and manufacture of biosimilar medicines for patients
